Effects of DPP-4 Inhibitors on Cardiovascular System in Type 2 Diabetes

被引：0
|
作者：
Ohno, Yasuhiro [1 ]
Tanaka, Yoichi [1 ]
Fujimoto, Mika [1 ]
Maruyama, Yasunori [1 ]
机构：
[1] Kinki Univ, Sakai Hosp, Fac Med, Sakai, Osaka, Japan
来源：
ENDOCRINE REVIEWS | 2014年 / 35卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
MON-1052
引用
收藏
页数：2
相关论文
共 50 条
  • [41] THE PLACEMENT OF DPP-4 INHIBITORS IN CLINICAL PRACTICE RECOMMENDATIONS FOR THE TREATMENT OF TYPE 2 DIABETES
    Davidson, Jaime A.
    ENDOCRINE PRACTICE, 2013, 19 (06) : 1050 - 1061
  • [42] Ten years of experience with DPP-4 inhibitors for the treatment of type 2 diabetes mellitus
    Sesti, Giorgio
    Avogaro, Angelo
    Belcastro, Sara
    Bonora, Benedetta Maria
    Croci, Marina
    Daniele, Giuseppe
    Dauriz, Marco
    Dotta, Francesco
    Formichi, Caterina
    Frontoni, Simona
    Invitti, Cecilia
    Orsi, Emanuela
    Picconi, Fabiana
    Resi, Veronica
    Bonora, Enzo
    Purrello, Francesco
    ACTA DIABETOLOGICA, 2019, 56 (06) : 605 - 617
  • [43] Novel DPP-4 inhibitors against diabetes
    Liu, Yang
    Hu, Yongzhou
    FUTURE MEDICINAL CHEMISTRY, 2014, 6 (07) : 793 - 808
  • [44] Haemodynamic effects of combination therapy with the DPP-4 inhibitor linagliptin and renin-angiotensin system inhibitors in patients with type 2 diabetes
    Cooper, M. E.
    Perkovic, V.
    Groop, P. -H.
    Hocher, B.
    Cescutti, J.
    Meinicke, T.
    Koitka-Weber, A.
    Thiemann, S.
    von Eynatten, M.
    DIABETOLOGIA, 2016, 59 : S366 - S367
  • [45] DPP-4 inhibitors
    Ahren, Bo
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 21 (04) : 517 - 533
  • [46] Transitioning from insulin to dipeptidyl-peptidase 4 (DPP-4) inhibitors for type 2 diabetes
    Hamrick, Irene
    Goblirsch, Matthew Joseph
    Tuan, Wen-Jan
    Beckham, Felicia
    GERIATRIC NURSING, 2022, 46 : 86 - 89
  • [47] Cardioprotective effects of dipeptidyl peptidase-4 (DPP-4) inhibitors independently of DPP-4
    Yamaguchi, T.
    Yasukatsu, I.
    Yamazaki, T.
    Nakamura, Y.
    Shimada, K.
    Yoshiyama, M.
    Iwao, H.
    EUROPEAN HEART JOURNAL, 2015, 36 : 777 - 777
  • [48] Cardiovascular safety profile of vildagliptin, anew DPP-4 inhibitor for the treatment of type 2 diabetes
    Kothny, W.
    Gimpelewicz, C.
    Byiers, S.
    Mills, D.
    Fitchet, M.
    DIABETOLOGIA, 2008, 51 : S367 - S367
  • [49] DPP-4 Inhibitors for the Inpatient Management of General Medicine and Surgery Patients with Type 2 Diabetes
    Reyes-Umpierrez, David
    Davis, Georgia
    Peng, Limin
    Pasquel, Francisco
    Vellanki, Priyathama
    Jacobs, Sol
    Fayfman, Maya
    Haw, Sonya
    Umpierrez, Guillermo E.
    DIABETES, 2017, 66 : A342 - A343
  • [50] Efficacy of DPP-4 inhibitors and predictive factor for the treatment in patients with type 2 diabetes mellitus
    Hahm, J. R.
    Lee, S. M.
    Jung, T. S.
    Jung, J. H.
    Chung, S. I.
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2012, 28 : 103 - 103
12345